Millendo Therapeutics, Inc. Merge With Tempest Therapeutics, Inc.

Millendo Therapeutics (NASDAQ: MLND), a biopharmaceutical company, merged with Tempest Therapeutics, a biotechnology company, in a transaction valued at $30 million.

Morrow Sodali acted as the proxy solicitor for the target in this transaction.

Find more information here: https://www.sec.gov/Archives/edgar/data/1544227/000110465921042769/tm2111026d1_ex99-1.htm